Leaders in sequence informatics and desktop sequence analysis join forces to provide users with enhanced, interoperable sequence search, analysis and data management capabilities

WESTBOROUGH, Mass.–GenomeQuest and Invitrogen today announced that the GenomeQuest™ 5.0 web-based sequence search, analysis and data management platform is now interoperable with Invitrogen’s Vector NTI Advance™ desktop sequence analysis solution.

Ronald Ranauro, President and CEO of GenomeQuest, Inc., said, “We are very pleased to announce that, based on numerous requests from mutual customers, the GenomeQuest platform is now closely interconnected with Invitrogen’s Vector NTI AdvanceTM software. The result of our collaboration expands the capabilities of both applications in the increasingly important realm of sequence search, analysis and data management.”

James Caffrey, Business Area Manager for Bioinformatics Software at Invitrogen, said, “This collaboration offers a ‘best of both worlds’ benefit to GenomeQuest and Vector NTI AdvanceTM users. The two software platforms are highly complementary, and the combination of our desktop solution with GenomeQuest’s web-based application and worldwide sequence database access will provide our many tens of thousands of users with new, compelling sequence search options.”

GenomeQuest 5.0 currently interoperates with Versions 9 and 10 of Vector NTI AdvanceTM, and will also interoperate with the upcoming Version 11. The connection between GenomeQuest™ and Vector NTI AdvanceTM provides the following user experience:

Users of GenomeQuest 5.0 can select sequences of interest through the application, then seamlessly send those sequences to Vector NTI AdvanceTM for deeper analysis, such as DNA assembly, multiple sequence alignment, protein analysis, and recombinant molecule construction.

Similarly, a Vector NTI AdvanceTM user can select sequences within that application, and then send those sequences to GenomeQuest 5.0 for advanced searching. GenomeQuest 5.0 then would leverage BLAST and other algorithms, against GenomeQuest 5.0’s collection of over 225 million sequences residing in multiple, frequently-updated databases worldwide including GQ-PAT, GenBank, RefSeq and DrugBank Pro. The software would then generate result sets that can be exported back into Vector NTI AdvanceTM for repeated rounds of analysis.

About GenomeQuest, Inc.

GenomeQuest, Inc. is the leading sequence informatics company providing applications and services to manage and mine the world’s sequence data. The company’s flagship product, GenomeQuest™, is a web-based sequence information platform that enables users to exploit genomic information resources including next-generation sequencing tools and worldwide biological sequence reference databases. GenomeQuest’s customers leverage high-speed algorithms and sophisticated analysis and reporting to transform data into functional knowledge, on-demand. GenomeQuest delivers genomic data access, management, and utility to over 150 leading life science companies worldwide. www.genomequest.com.